U.S. health regulators are investigating whether two transplant drugs made by Switzerland's Roche Holding AG and Novartis AG could be linked to a rare central nervous system disorder, the U.S. Food and Drug Administration said on Thursday.
Read full story
U.S. probes Roche, Novartis drugs on rare disorderPosted by UK Economy News
In UK financial news
10Apr 08 No Comments Yet - You can be the first to comment!Sorry, comments for this entry are closed at this time. |
|
Subscribe to RSS
